SYNCOMF
Invest with MTF
Invest Now
Invest in Syncom Formulation (India) with 2.03X leverage
Syncom Formulation (India) live price: ₹11.99. It opened at ₹12 vs previous close ₹12; intraday high/low: ₹12/₹12. The 50 & 200 DMA stand at ₹13.46/₹15.55.
Syncom Formulation (India) Performance
- Low
- ₹12
- High
- ₹12
- 52 Week Low
- ₹12
- 52 Week High
- ₹23
- Open Price₹12
- Previous Close₹12
- Volume1,040,334
- 50 DMA₹13.46
- 100 DMA₹14.39
- 200 DMA₹15.55
Investment Returns
- Over 1 Month -12.16%
- Over 3 Month -20.81%
- Over 6 Month -30.33%
- Over 1 Year -29.92%
Smart Investing Starts Here Start SIP with Syncom Formulation (India) for Steady Growth!
Syncom Formulation (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 16.3
- PEG Ratio
- 0.2
- Market Cap Cr
- 1,127
- P/B Ratio
- 2.8
- Average True Range
- 0.61
- EPS
- 0.73
- Dividend Yield
- 0
- MACD Signal
- -0.22
- RSI
- 33.34
- MFI
- 41.64
Syncom Formulation (India) Financials
Syncom Formulation (India) Technicals
EMA & SMA
Current Price
₹11.99
-0.07
(-0.58%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹12.88
- 50 Day
- ₹13.46
- 100 Day
- ₹14.39
- 200 Day
- ₹15.55
Resistance and Support
12.03
- R3 12.40
- R2 12.29
- R1 12.14
- S1 11.88
- S2 11.77
- S3 11.62
Syncom Formulation (India) Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-12 | Quarterly Results | |
| 2025-11-12 | Quarterly Results | |
| 2025-08-08 | Quarterly Results & A.G.M. | |
| 2025-05-19 | Audited Results | |
| 2025-02-10 | Quarterly Results & Others | To consider other business matters. per share(3%)Final Dividend |
Syncom Formulation (India) F&O
About Syncom Formulation (India)
- NSE Symbol
- SYNCOMF
- BSE Symbol
- 524470
- Managing Director
- Mr. Vijay Shankarlal Bankda
- ISIN
- INE312C01025
Similar Stocks to Syncom Formulation (India)
Syncom Formulation (India) FAQs
Syncom Formulation (India) share price is ₹11 As on 08 March, 2026 | 11:11
The Market Cap of Syncom Formulation (India) is ₹1127.1 Cr As on 08 March, 2026 | 11:11
The P/E ratio of Syncom Formulation (India) is 16.3 As on 08 March, 2026 | 11:11
The PB ratio of Syncom Formulation (India) is 2.8 As on 08 March, 2026 | 11:11
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.